Melanoma vaccines Journal Article


Authors: Perales, M. A.; Wolchok, J. D.
Article Title: Melanoma vaccines
Abstract: The identification of antigens on tumor cells has led to significant contributions to the field of immunotherapy. One of the most active areas under investigation in cancer immunotherapy is the development of vaccines against melanoma antigens. Induction of immunity against tumor antigens can follow multiple routes using different mechanisms. Crucial to the development of active immunization and other immunotherapies is the discovery and understanding of the molecular identity of antigens and the mechanisms involved in tumor immunity as well as escape from immunity. In this review, we will discuss strategies to induce active immunity against melanoma.
Keywords: t-lymphocytes; melanoma; tumor; clinical trials; vaccine; stage-iii; colony-stimulating-factor; high-risk melanoma; immunological adjuvant qs-21; heat-shock-protein; cytolytic; incomplete freunds-adjuvant; recruits dendritic cells; active-specific immunotherapy; peptides in-vivo
Journal Title: Cancer Investigation
Volume: 20
Issue: 7-8
ISSN: 0735-7907
Publisher: Informa Healthcare  
Date Published: 2002-01-01
Start Page: 1012
End Page: 1026
Language: English
ACCESSION: WOS:000179183300021
DOI: 10.1081/cnv-120005918
PROVIDER: wos
PUBMED: 12449735
Notes: Review -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok
  2. Miguel-Angel Perales
    918 Perales